Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders

Clara Camaschella

Research output: Contribution to journalArticle

Abstract

Genetic analysis of hemochromatosis has led to the discovery of a number of genes whose mutations disrupt iron homeostasis and lead to iron overload. The introduction of molecular tests into clinical practice has provided a tool for early diagnosis of these conditions. It has become clear that hemochromatosis includes a spectrum of disorders that range from simple biochemical abnormalities to chronic asymptomatic tissue damage in midlife to serious life-threatening diseases in young subjects. Molecular studies have identified the systemic loop that controls iron homeostasis and is centered on the hepcidin-ferroportin interaction. The complexity of this regulatory pathway accounts for the genetic heterogeneity of hemochromatosis and related disorders and raises the possibility that genes encoding components of the pathway may be modifiers of the main genotype. Molecular diagnosis has improved the classification of the genetic conditions leading to iron overload and identi-fied novel entities, characterized by both iron loading and variable degrees of anemia. Despite the progress in the diagnosis, classification, and mechanisms of iron overload disorders, the treatment of affected patients continues to rely on regular phlebotomy. Understanding the molecular circuitry of iron control may lead to the identification of potential therapeutic targets for novel treatment strategies to be used in association with or as an alternative to phlebotomy.

Original languageEnglish
Pages (from-to)3710-3717
Number of pages8
JournalBlood
Volume106
Issue number12
DOIs
Publication statusPublished - Dec 1 2005

Fingerprint

Hemochromatosis
Iron Overload
Homeostasis
Iron
Phlebotomy
Hepcidins
Gene Components
Genetic Heterogeneity
Anemia
Early Diagnosis
Therapeutics
Genotype
Gene encoding
Mutation
Genes
Tissue

ASJC Scopus subject areas

  • Hematology

Cite this

Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. / Camaschella, Clara.

In: Blood, Vol. 106, No. 12, 01.12.2005, p. 3710-3717.

Research output: Contribution to journalArticle

Camaschella, Clara. / Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. In: Blood. 2005 ; Vol. 106, No. 12. pp. 3710-3717.
@article{d1792674fbb1404e8e80d82467994288,
title = "Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders",
abstract = "Genetic analysis of hemochromatosis has led to the discovery of a number of genes whose mutations disrupt iron homeostasis and lead to iron overload. The introduction of molecular tests into clinical practice has provided a tool for early diagnosis of these conditions. It has become clear that hemochromatosis includes a spectrum of disorders that range from simple biochemical abnormalities to chronic asymptomatic tissue damage in midlife to serious life-threatening diseases in young subjects. Molecular studies have identified the systemic loop that controls iron homeostasis and is centered on the hepcidin-ferroportin interaction. The complexity of this regulatory pathway accounts for the genetic heterogeneity of hemochromatosis and related disorders and raises the possibility that genes encoding components of the pathway may be modifiers of the main genotype. Molecular diagnosis has improved the classification of the genetic conditions leading to iron overload and identi-fied novel entities, characterized by both iron loading and variable degrees of anemia. Despite the progress in the diagnosis, classification, and mechanisms of iron overload disorders, the treatment of affected patients continues to rely on regular phlebotomy. Understanding the molecular circuitry of iron control may lead to the identification of potential therapeutic targets for novel treatment strategies to be used in association with or as an alternative to phlebotomy.",
author = "Clara Camaschella",
year = "2005",
month = "12",
day = "1",
doi = "10.1182/blood-2005-05-1857",
language = "English",
volume = "106",
pages = "3710--3717",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders

AU - Camaschella, Clara

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Genetic analysis of hemochromatosis has led to the discovery of a number of genes whose mutations disrupt iron homeostasis and lead to iron overload. The introduction of molecular tests into clinical practice has provided a tool for early diagnosis of these conditions. It has become clear that hemochromatosis includes a spectrum of disorders that range from simple biochemical abnormalities to chronic asymptomatic tissue damage in midlife to serious life-threatening diseases in young subjects. Molecular studies have identified the systemic loop that controls iron homeostasis and is centered on the hepcidin-ferroportin interaction. The complexity of this regulatory pathway accounts for the genetic heterogeneity of hemochromatosis and related disorders and raises the possibility that genes encoding components of the pathway may be modifiers of the main genotype. Molecular diagnosis has improved the classification of the genetic conditions leading to iron overload and identi-fied novel entities, characterized by both iron loading and variable degrees of anemia. Despite the progress in the diagnosis, classification, and mechanisms of iron overload disorders, the treatment of affected patients continues to rely on regular phlebotomy. Understanding the molecular circuitry of iron control may lead to the identification of potential therapeutic targets for novel treatment strategies to be used in association with or as an alternative to phlebotomy.

AB - Genetic analysis of hemochromatosis has led to the discovery of a number of genes whose mutations disrupt iron homeostasis and lead to iron overload. The introduction of molecular tests into clinical practice has provided a tool for early diagnosis of these conditions. It has become clear that hemochromatosis includes a spectrum of disorders that range from simple biochemical abnormalities to chronic asymptomatic tissue damage in midlife to serious life-threatening diseases in young subjects. Molecular studies have identified the systemic loop that controls iron homeostasis and is centered on the hepcidin-ferroportin interaction. The complexity of this regulatory pathway accounts for the genetic heterogeneity of hemochromatosis and related disorders and raises the possibility that genes encoding components of the pathway may be modifiers of the main genotype. Molecular diagnosis has improved the classification of the genetic conditions leading to iron overload and identi-fied novel entities, characterized by both iron loading and variable degrees of anemia. Despite the progress in the diagnosis, classification, and mechanisms of iron overload disorders, the treatment of affected patients continues to rely on regular phlebotomy. Understanding the molecular circuitry of iron control may lead to the identification of potential therapeutic targets for novel treatment strategies to be used in association with or as an alternative to phlebotomy.

UR - http://www.scopus.com/inward/record.url?scp=28444466958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444466958&partnerID=8YFLogxK

U2 - 10.1182/blood-2005-05-1857

DO - 10.1182/blood-2005-05-1857

M3 - Article

C2 - 16030190

AN - SCOPUS:28444466958

VL - 106

SP - 3710

EP - 3717

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -